Nebivolol Hydrochloride
Who holds supplier records for Nebivolol Hydrochloride? 14 organisations hold a current record for Nebivolol Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), China (3), Italy (2) and France (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Nebivolol Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nebivolol-hydrochloride
Reading the evidence
- 14 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 11 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (14)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Nebivolol Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 31081, 25296 · latest filing Nov 2016
- Alkem Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 39313 · latest filing Mar 2024
- Cadila Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 21152 · latest filing Dec 2007
- FIS FABBRICA ITALIANA SINTETICI SPAItalyCEP Company GMP cert on recordActive DMF 22735 · latest filing Mar 2009
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 29996 · latest filing Feb 2016
- MSN PHARMACHEM PRIVATE LTDIndiaCEPActive DMF 24916 · latest filing May 2011
- Torrent PharmaceuticalsIndiaCEP Company GMP cert on recordActive DMF 22906 · latest filing Jun 2009
- Zhejiang Ausun Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 29730 · latest filing Sept 2015
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 30848 · latest filing Aug 2016
- CORDEN PHARMA CHENOVEFrance Company GMP cert on recordActive DMF 30052 · latest filing Dec 2015
- HONOUR LAB LTDIndia Company GMP cert on recordActive DMF 28627 · latest filing Sept 2014
- SMAART PHARMACEUTTICALSIndiaActive DMF 35332 · latest filing Oct 2021
- Jiangsu Weiqida Pharmaceutical Co., Ltd.ChinaCEP
- ItalyCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (11)
Certificates of Suitability on the EDQM register for Nebivolol Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2026-093 - Rev 00 Nebivolol hydrochloride, Process A | Sept 2026 | Inspected Jan 2024 Hungary |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2022-140 - Rev 03 Nebivolol hydrochloride, Non-micronised, micronised | Aug 2026 | Inspected May 2026 Italy |
| ALKEM LABORATORIES LIMITED Mumbai | IN | CEP 2024-481 - Rev 01 Nebivolol hydrochloride | Jul 2026 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2025-575 - Rev 00 Nebivolol hydrochloride, (1083) | Jun 2026 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2021-403 - Rev 02 Nebivolol hydrochloride | Apr 2026 | — |
| LUSOCHIMICA S.P.A. Casaletto Lodigiano | IT | CEP 2023-063 - Rev 02 Nebivolol hydrochloride | Mar 2026 | Inspected Feb 2026 Italy |
| TORRENT PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2023-122 - Rev 01 Nebivolol hydrochloride | May 2025 | — |
| F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio Maggiore | IT | CEP 2024-214 - Rev 00 Nebivolol hydrochloride, Micronised | Apr 2025 | Inspected Apr 2026 Italy |
| MSN PHARMACHEM PRIVATE LIMITED Sangareddy District | IN | CEP 2022-193 - Rev 02 Nebivolol hydrochloride, Crystalline, micronised and non-micronised | Apr 2025 | — |
| JIANGSU WEIQIDA PHARMACEUTICAL CO., LTD. Nantong City | CN | CEP 2022-069 - Rev 00 Nebivolol hydrochloride | Apr 2024 | — |
| CADILA PHARMACEUTICALS LIMITED Ankleshwar | IN | R0-CEP 2022-095 - Rev 00 Nebivolol hydrochloride | Aug 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Nebivolol Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- India · Inactive DMF 24821 · filed Mar 2011
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Nebivolol Hydrochloride is a selective beta-1 receptor blocker used in the treatment of hypertension and heart failure. It exhibits vasodilatory properties, which help in the reduction of blood pressure.
Chemical identity
- IUPAC name
- [(2R)-2-[(2R)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl]-[(2R)-2-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl]azanium chloride
- Canonical SMILES
- C1CC2=C(C=CC(=C2)F)O[C@H]1[C@@H](C[NH2+]C[C@H]([C@@H]3CCC4=C(O3)C=CC(=C4)F)O)O.[Cl-]
- InChIKey
- JWEXHQAEWHKGCW-VCVZPGOSSA-N
- Synonyms
- Bystolic API, bystolic, nebivolol hcl, r-067555, r067555
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- beta-Adrenergic Blocker
- Mechanism of action
- Adrenergic beta-Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Nebivolol Hydrochloride?
14 organisations hold an active US FDA Type II Drug Master File or a CEP for Nebivolol Hydrochloride: Hetero Drugs Limited (India), Alkem Laboratories Limited (India), Cadila Pharmaceuticals Limited (India), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), Macleods Pharmaceuticals Ltd. (India), MSN PHARMACHEM PRIVATE LTD (India), Torrent Pharmaceuticals (India) and Zhejiang Ausun Pharmaceutical Co., Ltd. (China), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Nebivolol Hydrochloride Drug Master Files are active?
Hetero Drugs Limited (DMF 31081, 25296), Alkem Laboratories Limited (DMF 39313), Cadila Pharmaceuticals Limited (DMF 21152), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 22735), Macleods Pharmaceuticals Ltd. (DMF 29996), MSN PHARMACHEM PRIVATE LTD (DMF 24916), Torrent Pharmaceuticals (DMF 22906) and Zhejiang Ausun Pharmaceutical Co., Ltd. (DMF 29730) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Nebivolol Hydrochloride records mean?
1 organisation has only inactive Type II DMFs for Nebivolol Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Nebivolol Hydrochloride have a European Certificate of Suitability?
Yes. 11 organisations hold a valid CEP for Nebivolol Hydrochloride on the EDQM register, including ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. Taizhou (CN), ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou (CN), ALKEM LABORATORIES LIMITED Mumbai (IN), MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN), HETERO DRUGS LIMITED Hyderabad (IN) and LUSOCHIMICA S.P.A. Casaletto Lodigiano (IT) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Nebivolol Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Nebivolol Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.